Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,267 public trials 445 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

A Randomized Phase II Study of Two Doses of Interferon Alfa-2a (IFN Alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3

NCT00000754

Conditions
AIDS-Related Complex, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +14 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • Ucsd, Avrc Crs La Jolla, California, United States
  • UCSD Maternal, Child, and Adolescent HIV CRS San Diego, California, United States
  • Univ. of Miami AIDS CRS Miami, Florida, United States
View Trial Details
Completed

A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months

NCT00000841

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Univ of Alabama at Birmingham Birmingham, Alabama, United States
  • Children's Hosp of Los Angeles Los Angeles, California, United States
  • Univ of Southern California / LA County USC Med Ctr Los Angeles, California, United States
  • UCLA CARE Ctr Los Angeles, California, United States
View all 87 locations
View Trial Details
Completed

A Study of Disease Progression and Anti-HIV Treatments

NCT00001068

Conditions
AIDS-Related Complex, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
View all 41 locations
View Trial Details
Completed

A Phase II Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 With or Without HIV-1 SF-2 RGP120 in HIV-1 Uninfected Adult Volunteers

NCT00000871

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB AVEG Birmingham, Alabama, United States
  • Public Health Enterprises Foundation, Inc. HIVNET San Francisco, California, United States
  • Denver Dept. of Health HIVNET Denver, Colorado, United States
  • Denver Public Health CRS Denver, Colorado, United States
View all 18 locations
View Trial Details
Completed

A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the Past

NCT00001029

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • USC CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Ucsd, Avrc Crs San Diego, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
View all 37 locations
View Trial Details
Completed

High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals

NCT00885703

Conditions
Bacterial Infections and Mycoses, Blood-Borne Infections, Central Nervous System Diseases, +23 more
Locations
  • University of Southern California CRS Los Angeles, California, United States
  • Byramjee Jeejeebhoy Medical College (BJMC) CRS Pune, Maharashtra, India
  • Kenya Medical Research Institute/Walter Reed Project Clinical Research Center (KEMRI/WRP) CRS Kericho, Rift Valley, Kenya
  • Moi University Clinical Research Center (MUCRC) CRS Eldoret, Kenya
View Trial Details
Completed

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

NCT00001044

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • St. Louis Univ. School of Medicine AVEG St Louis, Missouri, United States
  • Univ. of Rochester AVEG Rochester, New York, United States
  • JHU AVEG Pittsburgh, Pennsylvania, United States
  • UW - Seattle AVEG Seattle, Washington, United States
View Trial Details
Completed

Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS

NCT00001014

Conditions
AIDS-Related Complex, AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, +26 more
Locations
  • Ucsf Aids Crs San Francisco, California, United States
  • Rush Univ. Med. Ctr. ACTG CRS Chicago, Illinois, United States
  • Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU New Orleans, Louisiana, United States
  • Washington U CRS St Louis, Missouri, United States
View Trial Details

Related conditions